[Prodigiozan modulation of the specific activity of antidepressants].
The experiments carried out on mongrel male mice showed that bacterial lipopolysaccharide Prodigiozan inhibit the activity of P-450-dependent monooxygenases of the liver, thus changing the activity of antidepressants--amitriptyline and imipraminum. The data on biological activity were tested in "tail suspension" test. Prodigiozan exhibited no central effect. Changes in biotransformation processes after single administration of both drugs resulted in the delay and prolongation of the effect. Prodigiozan prevents the induction of microsomal enzymes caused by antidepressants. Amitriptyline do not affect the immunostimulating action of prodigiozan, whereas imipraminum inhibited prodigiozan activity.
Sibiriak
S V
SV
Krasilova
I L
IL
D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use; D000639:Amitriptyline / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology* / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D007099:Imipramine / Q000494:pharmacology* / Q000633:toxicity; D008297:Male; D051379:Mice; D011354:Prodigiozan / Q000494:pharmacology* / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000401:mortality; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000929:Antidepressive Agents, Tricyclic; D000639:Amitriptyline; D011354:Prodigiozan; D007099:Imipramine
Moduliatsiia prodigiozanom spetsificheskoĭ aktivnosti antidepressantov.